wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37391801-0763B36A-9795-4DA8-A0E1-887FF781944A
Q37391801-0763B36A-9795-4DA8-A0E1-887FF781944A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37391801-0763B36A-9795-4DA8-A0E1-887FF781944A
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.
P2860
Q37391801-0763B36A-9795-4DA8-A0E1-887FF781944A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37391801-0763B36A-9795-4DA8-A0E1-887FF781944A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e93501d0272124b9a58d89d2db912084950c63f
P2860
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.